US 9616015
Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
granted A61KA61K38/4853A61K9/0019
Quick answer
US patent 9616015 (Formulations of human tissue kallikrein-1 for parenteral delivery and related methods) held by DiaMedica Inc. expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- DiaMedica Inc.
- Grant date
- Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K38/4853, A61K9/0019, A61P, A61P3/10